Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.13
+0.24 (2.43%)
Mar 9, 2026, 2:49 PM EDT - Market open
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.81 billion as of March 9, 2026. Its market cap has increased by 164.46% in one year.
Market Cap
1.81B
Enterprise Value
1.27B
1-Year Change
164.46%
Ranking
Category
Stock Price
$10.13
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $1.81B, a decrease of -40.34%. That is a compound annual growth rate of -8.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.83B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Definium Therapeutics | 1.76B |
| Enliven Therapeutics | 1.76B |
| Sarepta Therapeutics | 1.75B |
| Galecto | 1.74B |